Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT05089461
What this trial is testing

Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor

Who this might be right for
Advanced Malignant Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT05807542
What this trial is testing

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

Who this might be right for
Esophagus Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04615468
What this trial is testing

TQ-B3525 in Subjects With Relapsed/Refractory Peripheral T-cell Lymphoma（PTCL）

Who this might be right for
Peripheral T-cell Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 78
Testing effectiveness (Phase 2)UnknownNCT00927797
What this trial is testing

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Who this might be right for
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Heidelberg University 185
Testing effectiveness (Phase 2)Study completedNCT03809013
What this trial is testing

A Open-label, Single-arm, Multicenter, Phase II Study of RC48-ADC to Evaluate the Efficacy and Safety of Subjects With HER2 Overexpressing Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
RemeGen Co., Ltd. 64
Testing effectiveness (Phase 2)Ended earlyNCT05265013
What this trial is testing

ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With or Without Metastases

Who this might be right for
Head and Neck Cancer
Rakuten Medical, Inc. 16
Testing effectiveness (Phase 2)Looking for participantsNCT06383013
What this trial is testing

BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Blue Blood Biotech Corp. 96
Large-scale testing (Phase 3)UnknownNCT03500380
What this trial is testing

RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Who this might be right for
Breast NeoplasmsBreast DiseasesCapecitabine+3 more
RemeGen Co., Ltd. 301
Testing effectiveness (Phase 2)UnknownNCT02941562
What this trial is testing

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

Who this might be right for
Rectal Cancer, Radiotherapy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)UnknownNCT03332888
What this trial is testing

Safety of HMA-CD20 in Patients With HFrEF

Who this might be right for
Heart Failure With Reduced Ejection Fraction
Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud 10
Testing effectiveness (Phase 2)UnknownNCT02132988
What this trial is testing

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Mackay Memorial Hospital 110
Testing effectiveness (Phase 2)UnknownNCT03349203
What this trial is testing

Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer

Who this might be right for
EGF-R Positive Non-Small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 60
Early research (Phase 1)Study completedNCT00083603
What this trial is testing

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Ended earlyNCT01914718
What this trial is testing

Dose-adjusted EPOCH-R in MYC Positive DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 26
Testing effectiveness (Phase 2)Study completedNCT02829918
What this trial is testing

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerBiliary Tract Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 54
Testing effectiveness (Phase 2)Looking for participantsNCT07495124
What this trial is testing

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

Who this might be right for
Fallopian Tube CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma
University of Washington 26
Testing effectiveness (Phase 2)Study completedNCT02909959
What this trial is testing

Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder

Who this might be right for
Autism Spectrum DisorderAutistic DisorderNeurodevelopmental Disorder+1 more
University of North Carolina, Chapel Hill 48
Testing effectiveness (Phase 2)Study completedNCT00309179
What this trial is testing

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Who this might be right for
Advanced Colorectal Cancer
Eisai Inc. 41
Testing effectiveness (Phase 2)Study completedNCT01809379
What this trial is testing

Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Ruhr University of Bochum 69
Testing effectiveness (Phase 2)UnknownNCT04992988
What this trial is testing

Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaToripalimabRecurrent Nasopharyngeal Squamous Cell Carcinoma
Cancer Hospital of Guangxi Medical University 40
Next Page